1. Home
  2. COEP vs PSHG Comparison

COEP vs PSHG Comparison

Compare COEP & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • PSHG
  • Stock Information
  • Founded
  • COEP 2017
  • PSHG 2010
  • Country
  • COEP United States
  • PSHG Greece
  • Employees
  • COEP N/A
  • PSHG N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • PSHG Marine Transportation
  • Sector
  • COEP Health Care
  • PSHG Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • PSHG Nasdaq
  • Market Cap
  • COEP 27.4M
  • PSHG 23.1M
  • IPO Year
  • COEP N/A
  • PSHG N/A
  • Fundamental
  • Price
  • COEP $10.72
  • PSHG $1.68
  • Analyst Decision
  • COEP
  • PSHG
  • Analyst Count
  • COEP 0
  • PSHG 0
  • Target Price
  • COEP N/A
  • PSHG N/A
  • AVG Volume (30 Days)
  • COEP 59.5K
  • PSHG 100.8K
  • Earning Date
  • COEP 08-15-2025
  • PSHG 07-30-2025
  • Dividend Yield
  • COEP N/A
  • PSHG N/A
  • EPS Growth
  • COEP N/A
  • PSHG 6.25
  • EPS
  • COEP N/A
  • PSHG 1.56
  • Revenue
  • COEP $62,874.00
  • PSHG $84,042,000.00
  • Revenue This Year
  • COEP N/A
  • PSHG N/A
  • Revenue Next Year
  • COEP N/A
  • PSHG $23.25
  • P/E Ratio
  • COEP N/A
  • PSHG $1.08
  • Revenue Growth
  • COEP N/A
  • PSHG N/A
  • 52 Week Low
  • COEP $2.31
  • PSHG $1.31
  • 52 Week High
  • COEP $13.70
  • PSHG $2.34
  • Technical
  • Relative Strength Index (RSI)
  • COEP 55.11
  • PSHG 40.64
  • Support Level
  • COEP $11.30
  • PSHG $1.68
  • Resistance Level
  • COEP $11.46
  • PSHG $1.88
  • Average True Range (ATR)
  • COEP 0.95
  • PSHG 0.11
  • MACD
  • COEP -0.05
  • PSHG -0.02
  • Stochastic Oscillator
  • COEP 38.82
  • PSHG 3.70

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About PSHG Performance Shipping Inc.

Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.

Share on Social Networks: